A carregar...
Immune Checkpoint Inhibitor Can Reduce HCV-RNA without Liver Damage
Recently, immune checkpoint inhibitors (iCIs) have been used to treat cancers. Once some of the iCIs for the treatment of hepatocellular carcinoma (HCC) are certified in clinical trials, they are likely be administered to HCC patients with hepatitis C virus (HCV). However, the immunopathogenesis of...
Na minha lista:
| Publicado no: | Intern Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Japanese Society of Internal Medicine
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7578607/ https://ncbi.nlm.nih.gov/pubmed/32522918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.3726-19 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|